Perspective Therapeutics Inc (AMEX: CATX) on Friday, soared 0.48% from the previous trading day, before settling in for the closing price of $2.07. Within the past 52 weeks, CATX’s price has moved between $1.60 and $10.06.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -9.86%. The company achieved an average annual earnings per share of 0.79%. With a float of $61.66 million, this company’s outstanding shares have now reached $74.34 million.
Perspective Therapeutics Inc (CATX) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Perspective Therapeutics Inc is 17.06%, while institutional ownership is 63.29%. The most recent insider transaction that took place on Nov 12 ’25, was worth 19,946. In this transaction Director of this company bought 9,498 shares at a rate of $2.10, taking the stock ownership to the 9,864 shares. Before that another transaction happened on Mar 28 ’25, when Company’s Chief Executive Officer bought 22,026 for $2.24, making the entire transaction worth $49,384. This insider now owns 59,383 shares in total.
Perspective Therapeutics Inc (CATX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.24 earnings per share (EPS) for the period topping the consensus outlook (set at -0.25) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.35 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.95% during the next five years compared to -9.86% drop over the previous five years of trading.
Perspective Therapeutics Inc (AMEX: CATX) Trading Performance Indicators
Perspective Therapeutics Inc (CATX) is currently performing well based on its current performance indicators. A quick ratio of 8.66 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 144.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.46, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.36 in one year’s time.
Technical Analysis of Perspective Therapeutics Inc (CATX)
The latest stats from [Perspective Therapeutics Inc, CATX] show that its last 5-days average volume of 2.5 million was superior to 1.04 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 9.96%.
During the past 100 days, Perspective Therapeutics Inc’s (CATX) raw stochastic average was set at 2.36%, which indicates a significant decrease from 7.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.19 in the past 14 days, which was lower than the 0.28 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.24, while its 200-day Moving Average is $3.08. Now, the first resistance to watch is $2.19. This is followed by the second major resistance level at $2.31. The third major resistance level sits at $2.38. If the price goes on to break the first support level at $2.00, it is likely to go to the next support level at $1.93. Assuming the price breaks the second support level, the third support level stands at $1.81.
Perspective Therapeutics Inc (AMEX: CATX) Key Stats
Market capitalization of the company is 154.62 million based on 74,338K outstanding shares. Right now, sales total 1,450 K and income totals -79,280 K. The company made 290 K in profit during its latest quarter, and -21,490 K in sales during its previous quarter.
